Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 519

Results For "RAT"

7999 News Found

AIIA signs MoU with AIST
Policy | October 09, 2022

AIIA signs MoU with AIST

The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines


LISSUN announces 2nd edition of its campaign -'#LISSUNToYourMind'
Startup | October 09, 2022

LISSUN announces 2nd edition of its campaign -'#LISSUNToYourMind'

Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"


ICON selected by BARDA to conduct anthrax vaccine clinical trial
Clinical Trials | October 09, 2022

ICON selected by BARDA to conduct anthrax vaccine clinical trial

This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.


India committed to promote green and climate resilient healthcare facilities: Dr Pawar
Sustainability | October 09, 2022

India committed to promote green and climate resilient healthcare facilities: Dr Pawar

Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW


Biocon Foundation receives Mahatma Award 2022
News | October 09, 2022

Biocon Foundation receives Mahatma Award 2022

The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities


Lupin partners global Agencies to support tuberculosis prevention treatment
News | October 09, 2022

Lupin partners global Agencies to support tuberculosis prevention treatment

Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price


Thermo Fisher Scientific emphasizes on the need for more disruptive technologies
Medical Device | October 09, 2022

Thermo Fisher Scientific emphasizes on the need for more disruptive technologies

Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.


Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant
Drug Approval | October 09, 2022

Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant

The company increases its efficiency and is able to face the growing demand for its services.


Pfizer acquires Global Blood Therapeutics
News | October 09, 2022

Pfizer acquires Global Blood Therapeutics

Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community


Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial
Clinical Trials | October 09, 2022

Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial

Study achieves primary endpoint of radiographic progression-free survival